Nearly 40 years ago, advocates made the case to the DEA’s own judge that cannabis did not meet the definition of a Schedule I controlled substance. Their case is exponentially stronger now.
The post NORML Op-Ed: DEA’s Marijuana Hearing Is a Good Opportunity for Advocates to Make the Case for Rescheduling appeared first on NORML.
NORML Summer ‘26 Intern Ben Bailey provides an update on Georgia’s medical cannabis legislation The post A Significant Step Forward
“Most participants were supportive of legal access to medical cannabis, open to using it in their own practice, and interested
PURCHASE 3 PRODUCTS, GET ONE FREE.
EVERY TIME.